Announcements Trials

Browse Landscape

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Gemcitabine 54 130-nm albumin-bound paclitaxel 29 Magnetic Resonance Spectroscopy 21 Taxes 18 Fluorouracil 18 Specimen Handling 17 Oxaliplatin 17 Leucovorin 17 Drug Therapy 17 Albumin-Bound Paclitaxel 17 Irinotecan 14 pembrolizumab 13 Cyclophosphamide 11 Blood Specimen Collection 11 Biopsy 11 fludarabine 10 Radiosurgery 9 irinotecan sucrosofate 8 folfirinox 6 Magnetic Resonance Imaging 6 Cetuximab 6 Bevacizumab 6 dehydroftorafur 5 Surveys and Questionnaires 5 Nivolumab 5 Endoscopic Ultrasound-Guided Fine Needle Aspiration 5 sintilimab 4 olaparib 4 balstilimab 4 Surgical Procedures, Operative 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Pancreatic Neoplasms × Biguanides × Clear all

NCT05663515 2026-06-02

EXCEED

AstraZeneca

24,000 enrolled

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡